AVXL Quote, Trading Chart, Anavex Life Sciences Corp.
home / stock / avxl / avxl quote
$12.83 Last:
-4.47% Change Percent:
$13.57 Open:
$12.83 Previous Close:
$14.23 High:
$12.145 Low:
3,784,589 Volume:
03/04/2021 04:55:17 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-03-04 | 13.57 | 12.83 | 14.23 | 12.145 | 3,784,589 |
| 2021-03-03 | 13.91 | 13.43 | 14.5899 | 13.14 | 1,766,825 |
| 2021-03-02 | 13.02 | 13.92 | 15.47 | 12.89 | 5,139,443 |
| 2021-03-01 | 13.06 | 12.94 | 13.319 | 12.52 | 1,426,363 |
| 2021-02-26 | 13.17 | 13.02 | 13.61 | 12.57 | 1,150,973 |
| 2021-02-25 | 12.4 | 13.06 | 13.74 | 12.26 | 2,119,337 |
| 2021-02-24 | 13.18 | 12.36 | 13.19 | 12.3 | 1,499,412 |
| 2021-02-23 | 12.27 | 12.07 | 12.4799 | 11.4 | 2,307,196 |
| 2021-02-22 | 12.79 | 12.89 | 13.48 | 12.5838 | 1,619,309 |
| 2021-02-19 | 12.75 | 12.54 | 12.94 | 12.37 | 1,159,924 |
| 2021-02-18 | 12.62 | 12.62 | 12.87 | 12.05 | 1,638,867 |
| 2021-02-17 | 12.696 | 12.73 | 13.57 | 12.44 | 1,618,699 |
| 2021-02-16 | 13.48 | 13.22 | 13.67 | 12.76 | 2,071,773 |
| 2021-02-15 | 12.36 | 13.21 | 13.9 | 11.8 | 2,290,887 |
| 2021-02-12 | 12.36 | 13.21 | 13.9 | 11.8 | 2,285,236 |
| 2021-02-11 | 12.9086 | 12.705 | 13.62 | 12.2 | 3,132,700 |
| 2021-02-10 | 15.07 | 13.67 | 16.04 | 13.4 | 4,136,574 |
| 2021-02-09 | 13.5 | 14.99 | 15.04 | 13.13 | 4,039,403 |
| 2021-02-08 | 13.06 | 14.1 | 14.44 | 13.06 | 7,955,685 |
| 2021-02-05 | 13.35 | 12.39 | 13.76 | 11.3 | 15,583,326 |
Anavex Life Sciences Corp. Company Name:
AVXL Stock Symbol:
NASDAQ Market:
Anavex Life Sciences Corp. Website:
News, Short Squeeze, Breakout and More Instantly...
-
NEW YORK, March 04, 2021 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental dis...
-
NEW YORK, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diso...
-
NEW YORK, Feb. 19, 2021 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diso...